The alert follows a wave of warning letters the agency sent to Supergoop!, Vacation Inc. and three other popular brands, accusing them of peddling whipped, mousse and foam sunscreens that flout ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...

Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved ...

Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

An update from Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) is now available. Shanghai Henlius Biotech, Inc. announced that its New Drug ...

PASADENA, Calif.-- (BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...

FDA accepted a new drug application for nonhormonal elinzanetant to treat hot flashes associated with menopause. If approved, elinzanetant would be the second nonhormonal option for menopausal women.

U.S. FDA Accepts New Drug Application for Merck’s DOR/ISL Once-Daily Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1.

Achieve Life Sciences, Inc. has submitted a New Drug Application (NDA) to the U.S. FDA for cytisinicline, which, if approved, would be the first new pharmacotherapy for nicotine dependence in 20 ...

KELOWNA, BC/ ACCESSWIRE/ January 30, 2024/ Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announces that, on January 29, it submitted its much-anticipated Investigational ...

September 1, 2006 (Vol. 26, No. 15) Knowing Early On Exactly What Is Needed Will Save Headaches Down the Road Understanding the requirements behind the FDA’s New Drug Application process can ...